A useful benchmark we use at SheMed is a minimum weight loss of approximately 1% of starting body weight per month at a stable dose
Drug compounding is allowed when drugs are on the FDA's shortage list, or in circumstances when a patient can't take a version of a drug made by a pharmaceutical company and they need an alternative
The SURMOUNT trial program demonstrated that tirzepatide produces approximately 20.9% average weight loss at maximum doses, representing a 6 percentage point improvement over semaglutide
PEPTIDE SOURCES & SAFETY - My guest on the Huberman Lab podcast out now is Dr Abud Bakri, MD @abud_bakri We discuss peptides: BPC, GLPs (incl Retatrutide), GHK-Cu, Pinealon, Epitalon, TB500 and Thymosin, and more
Zonder blijvende veranderingen in voeding en beweging komt het gewicht vaak terug
Slowing Gastric Emptying: It slows down the rate at which food leaves the stomach, promoting a feeling of fullness